Abstract:Objective To explore protective effect of neutralizing Interleukin-17 (IL-17) on Bleomycin (BLM)- induced pulmonary fibrosis in mice. Methods Totally 96 mice were randomly divided into antibody intervention group (antibody group), IgG group, BLM group and control group (n = 24). Endotracheal injection of BLM was performed resulting in acute lung injury and pulmonary fibrosis in mice. Mice in control group received normal saline. Mice were treated with IL-17 neutralizing antibody, IgG2A or BLM at day 4, 9, 14, 19, 22 in antibody group, IgG2A group and BLM group, respectively. Mice were sacrificed 7, 14, 21, 28 days, after cell culture, bronchoalveolar lavage fluid (BALF) was used to detect cell count. IL-1 β, IL-10, IL-17A and IFN-γ were measured by Elisa kits. Hydroxyprine (HYP), malonaldehyde (MDA) and reactive oxygen species (ROS) in lung tissue were determined. Histological characterization of pulmonary fibrosis was evaluated. Results Number of lymph, monocytes, neutrophils, concentration of IL-1β, IL-10, IFN-γ, IL-17A, and expression of HYP, MDA and ROS were decreased significantly in antibody group when compared with those in BLM group (P < 0.05 ). No obvious differences in the mentioned indexes were witnessed between IgG group and BLM group (P > 0.05). Conclusions Blockage of cytokine IL-17A effectively reduces BLM induced pulmonary fibrosis in mice through mediating inflammatory response.